Company intelligence / Profile preview

Anvita Pharma

Ownership: Private
Development stage: Commercial

Overview

Anvita Pharma is Indonesia’s first privately owned API company specializing in small molecule production. It operates a GMP-certified facility, providing end-to-end CDMO services to local and international pharmaceutical partners, with a mission to strengthen healthcare resilience across ASEAN by supporting the development of essential medicines. No clinical trial results or proprietary drug programs are reported.

Therapeutic areas: OtherRare Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

local and international pharmaceutical companies

Beyond the preview

Go deeper on Anvita Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anvita Pharma.

Explore the full profile